Peter Bross, MD

Acting chief of the oncology branch of the Center for Biologics Evaluation and Research at the FDA

Articles by Peter Bross, MD

Peter Bross, MD, on the Importance of Transparency and Communication With the FDA

July 24th 2022

The chief of the oncology branch of the Center for Biologics Evaluation and Research at the FDA discussed how academia and industry can work best with regulatory agencies.

Peter Bross, MD, on Regulating Cell Therapies: Lessons Learned

ByPeter Bross, MD

June 29th 2022

The acting chief of the oncology branch of the Center for Biologics Evaluation and Research at the FDA discussed the evolution of cell therapies in the past decade.

Peter Bross, MD

Articles by Peter Bross, MD

Peter Bross, MD, on the Importance of Transparency and Communication With the FDA

Peter Bross, MD, on Regulating Cell Therapies: Lessons Learned

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial